北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 血液科  > 期刊论文
学科主题: 临床医学
题名:
DOES ALLOGENEIC HSCT PLAY A ROLE IN FIRST-LINE POST-REMISSION THERAPY FOR AML PATIENTS WITH T(8;21) IN FIRST COMPLETE REMISSION?
作者: Zhu, H. -H.; Zhang, X. -H.; Jiang, H.; Liu, D. -H.; Chen, H.; Jiang, Q.; Xu, L. -P.; Lu, J.; Han, W.; Bao, L.; Wang, Y.; Chen, Y. -H.; Lu, X. -J.; Wang, J. -Z.; Wang, F. -R.; Qin, Y. -Z.; Lai, Y-Y.; Liu, R. -R.; Liu, K. -Y.; Jiang, B.; Huang, X. -J.
刊名: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
发表日期: 2012-02-01
卷: suppl.2, 期:2, 页:S325-S325
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Hematology ; Immunology ; Transplantation
研究领域[WOS]: Hematology ; Immunology ; Transplantation
语种: 英语
WOS记录号: WOS:000299398600323
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51049
Appears in Collections:北京大学第二临床医学院_血液科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Peoples Hosp, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing 100871, Peoples R China

Recommended Citation:
Zhu, H. -H.,Zhang, X. -H.,Jiang, H.,et al. DOES ALLOGENEIC HSCT PLAY A ROLE IN FIRST-LINE POST-REMISSION THERAPY FOR AML PATIENTS WITH T(8;21) IN FIRST COMPLETE REMISSION?[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION,2012,suppl.2(2):S325-S325.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhu, H. -H.]'s Articles
[Zhang, X. -H.]'s Articles
[Jiang, H.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhu, H. -H.]‘s Articles
[Zhang, X. -H.]‘s Articles
[Jiang, H.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace